Evidence map›Paper›PMID 23240883›Full record

ArticleJournal of proteome research2013

Feasibility of identifying the tobacco-related global metabolome in blood by UPLC-QTOF-MS.

Ping-Ching Hsu, Bin Zhou, Yi Zhao, Habtom W Ressom, Amrita K Cheema, Wallace Pickworth, Peter G Shields

Open access · bronzeAbstract read
In one paragraph

Article in Journal of proteome research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 40 citations in OpenAlex.

  1. Associations between Metabolomic Signatures of Persistent Smoking Effects and Lung Cancer Risk among Former Smokers.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Electronic cigarette vapor disrupts key metabolic pathways in human lung epithelial cells.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. A Review of Pulmonary Toxicity of Electronic Cigarettes in the Context of Smoking: A Focus on Inflammation.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2017
    Review
  15. Article
  16. Article
  17. Article
  18. Cigarette smoking behaviour and blood metabolomics.International journal of epidemiology · 2016
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Ping-Ching HsuOhio State University Comprehensive Cancer Center, Columbus, Ohio, USA.
Bin Zhou
Yi Zhao
Habtom W Ressom
Amrita K Cheema
Wallace Pickworth
Peter G Shields
The Ohio State University · USUniversity of Washington · USBattelle · USGeorgetown University · USGeorgetown University Medical Center · US

Funding

Youth Type 1 Diabetes Nonadherence Prevention ProgramM01RR013297 · NCRR · GEORGETOWN UNIVERSITY · PI AISEN, PAUL S. · 1999 to 2004
$14.1M
MUTAGENESIS OF THE PRB POCKET DOMAINR01CA064402 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI DYSON, NICHOLAS J · 1994 to 2015
$4.1M
Laboratory based Evaluation of Tobacco Harm ReductionR01CA114377 · NCI · GEORGETOWN UNIVERSITY · PI RICE, JERRY M · 2007 to 2010
$728k
NCI NIH HHS 1R01 CA114377−01A2NCI NIH HHS N01 PC064402NCI NIH HHS NCI N01-PC-64402NCI NIH HHS R01 CA114377NCRR NIH HHS M01 RR013297
6 · The paper itself

Abstract

Metabolomics is likely an ideal tool to assess tobacco smoke exposure and the impact of cigarette smoke on human exposure and health. To assess reproducibility and feasibility of this by UPLC-QTOF-MS, three experiments were designed for the assessment of smokers' blood. Experiment I was an analysis of 8 smokers with 8 replicates. Experiment II was an analysis of 62 pooled quality control (QC) samples from 7 nonsmokers' plasma placed as every tenth sample among a study of 613 samples from 160 smokers. Finally, to examine the feasibility of metabolomic study in assessing smoke exposure, Experiment III consisted of 9 smokers and 10 nonsmokers' serum to evaluate differences in their global metabolome. There was minimal measurement and sample preparation variation in all experiments, although some caution is needed when analyzing specific parts of the chromatogram. When assessing QC samples in the large scale study, QC clustering indicated high stability, reproducibility, and consistency. Finally, in addition to the identification of nicotine metabolites as expected, there was a characteristic profile distinguishing smokers from nonsmokers. Metabolites selected from putative identifications were verified by MS/MS, showing the potential to identify metabolic phenotypes and new metabolites relating to cigarette smoke exposure and toxicity.

Indexed as

MetabolomeChromatography, High Pressure LiquidCross-Sectional StudiesFeasibility StudiesHumansNicotineObserver VariationQuality ControlReproducibility of ResultsSmokingTandem Mass SpectrometryTobacco ProductsNicotine

Identifiers

PMID23240883
PMCPMC3579455
OpenAlexW2090798613

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.